Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new paper, published by the Tammaro lab in the Proceedings of the National Academy of Sciences (PNAS), shines new light on potential sites for pharmacological intervention within TMEM16A channels.

The TMEM16A calcium-activated chloride channels are involved in vital physiological functions, including the control of artery tone and nociception. Dysfunction of these ion channels leads to pathology; thus, they are proposed therapeutic targets. In spite of this, our knowledge of TMEM16A pharmacology lags behind that of other ion channels. Defining the mode of action and binding sites for synthetic test compounds lays the foundation for the development of new TMEM16A-interacting drugs.

The Tammaro Lab and collaborators demonstrate that intracellular calcium triggers a conformational change in the outer mouth of the channel, which enables entry of small molecules into the pore. The explanation of this structural rearrangement demonstrates a crucial site for pharmacological intervention and sheds light on a new aspect of calcium-gating in the TMEM16A channel. The study is published in PNAS (An outer-pore gate modulates the pharmacology of the TMEM16A channel | PNAS)

Similar stories

Fran Platt awarded 2023 Thudichum Medal

Pharmacology Head of Department, Professor Fran Platt, has been announced as the winner of the 2023 Thudichum Medal, presented by the Biochemical Society.

Join Pharmacology as the next Blaschko Fellow

Two year fellowship, offered in association with Linacre College, which offers full salary support, funding for travel and consumables and college accommodation. Join one of the existing groups in Pharmacology and develop your own research programme.

Sir Jon Symonds joins Pharmacology as a Visiting Fellow

The Department of Pharmacology is delighted to announce the appointment of Sir Jonathan Symonds CBE, Chair of the Board of GlaxoSmithKline, as a Visiting Fellow. Jon has been Chairman of the Board at GSK since September 2019.

Rosalind Franklin Institute and Pharmacology announce strategic partnership in Next Generation Chemistry

The Rosalind Franklin Institute and the University of Oxford’s Department of Pharmacology have entered into a strategic partnership for Next Generation Chemistry.